Progress and potential: The Cancer Moonshot
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference15 articles.
1. Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19;Asnani;Leukemia,2020
2. Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma;Burga,2019
3. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis;Evrard,2020
4. Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2);Finney Rutten;Trials,2020
5. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma;Liu;Nat. Med.,2019
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Precision Nutrition and Cancer;Precision Nutrition;2024
2. Maternal Mortality;Obstetrics & Gynecology;2023-12-21
3. Integration of Computational Docking into Anti-Cancer Drug Response Prediction Models;Cancers;2023-12-21
4. The Cancer Moonshot, the role of in vitro models, model accuracy, and the need for validation;Nature Nanotechnology;2023-08-29
5. Local Social Vulnerability as a Predictor for Cancer-Related Mortality Among US Counties;The Oncologist;2023-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3